Advertisement

Topics

Recordati Rare Diseases Canada Inc. Company Profile

16:42 EST 17th February 2019 | BioPortfolio

Recordati Rare Diseases Canada Inc. is a biopharmaceutical company committed to providing often overlooked orphan therapies to underserved rare disease communities in Canada. Recordati Rare Diseases Canada Inc. and our sister company, Orphan Europe, are part of the rare disease business within the Recordati Group, a public global pharmaceutical company committed to the research and development of new specialties with a focus on treatments for rare disease.


News Articles [1725 Associated News Articles listed on BioPortfolio]

Recordati Rare Diseases Canada Inc. Announces the Canadian Launch of PANHEMATIN®

Recordati Rare Diseases Canada Inc., a biopharmaceutical company providing orphan therapies for patients with rare diseases, today announced the commercial launch of PANHEMATIN®,...

How Technology is Reshaping the Rare Disease Landscape

PRA has recently released a white paper about technology’s effects on rare disease research. Approximately 7,000 rare diseases affect an estimated 350 million people worldwide, and with diagnostic ...

Balancing expectations: An unmet need in the orphan disease arena

There are between 6000 and 8000 rare diseases in the world, and one in ten people in Europe and the US have a rare disease; 75% of rare diseases affect children, and 30% of rare disease patients die b...

Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita

Ultragenyx Pharmaceutical (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, Kyowa Hakko Kirin and Kyowa Kirin In...

AI technology identifies rare genetic diseases from facial photos

A new artificial intelligence (AI) technology that can identify rare genetic diseases through analyzing an image of a patient's face could help cut diagnosis times for rare diseases and provide mor...

Development of medicines for rare diseases

A disease is considered rare if fewer than five in 10,000 people have it. Around 30 million people in the European Union (EU) suffer from a debilitating rare disease, which means one in 17 people. Fin...

A POLICY FAILED BY OFFICIALS

In a glaring example of bureaucratic insensitivity towards a subject as grave as providing the much needed financial assistance to millions of hapless patients suffering from rare diseases, the Union ...

Rare Diseases: What Makes China A Rising Star?

Top corporate executives are increasingly turning their attention to rare diseases in China as changing regulatory policies provide a rare...    

Drugs and Medications [74 Associated Drugs and Medications listed on BioPortfolio]

Neoprofen [recordati rare diseases, inc.]

These highlights do not include all the information needed to use NEOPROFEN safely and effectively. See full prescribing information for NEOPROFEN. NEOPROFEN (ibuprofen lysine) Injection, for intraven...

Panhematin [recordati rare diseases, inc.]

Panhematin Hemin For Injection Rx only For intravenous infusion only.

Cystadane [orphan europe sarl]

NA

Nitrogen [praxair canada, inc.]

NA

Oxygen [praxair canada, inc.]

NA

PubMed Articles [2944 Associated PubMed Articles listed on BioPortfolio]

Orthodontically-Relevant Manifestations in People with Rare Diseases.

Approximately 15% of all rare diseases occur with orofacial manifestations. Symptoms and manifestations of relevance to orthodontists represent a considerable proportion of these diseases and require ...

Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan's National Health Insurance Research Database.

High-cost orphan drugs are becoming increasingly available to treat rare diseases that affect a relatively small population. Little attention has been given to the prevalence of rare diseases and thei...

Impact Of The Priority Review Voucher Program On Drug Development For Rare Pediatric Diseases.

Only an estimated 5 percent of rare pediatric diseases have a treatment, although collectively they affect more than ten million children in the US. To stimulate drug development for rare pediatric d...

What Precision Medicine Can Learn from Rare Genetic Disease Research and Translation.

The goal of this article is to examine the intersections of precision health and rare diseases. Specifically, we propose 3 lessons from the last decade of applying genomics to rare diseases: (1) preci...

Treatment networks and associations of patients with rare diseases.

Patients' associations are an example of biosocial groups, since their formation is motivated by common biological characteristics, such as rare diseases, and they are sometimes included in social mov...

Clinical Trials [3872 Associated Clinical Trials listed on BioPortfolio]

Diagnostic Research in Patients With Rare Diseases - Solving the Unsolved Rare Diseases

The DiRiP study will enroll patients (n = 3500) with unclear rare diseases and suspected genetic reasons. In group 1 (n = 500) subjects are clinically characterized in the context of outpa...

Multi-center Clinical Study on the Diagnosis and Treatment Management of Rare Neurological Disease in Children

The incidence of rare diseases is extremely low, the disease is numerous, the symptoms are serious, and the detection technology is complicated. Countries have different definitions of rar...

The Canadian Glomerulonephritis Registry and Translational Research Initiative

Glomerulonephritis (GN) is one of the most important causes of kidney failure in Canada. These comprise a group of "rare" diseases (

Finding Genes for Rare Diseases

This study will help the investigator understand the pathogenesis of different rare genetic conditions and to establish database of rare genetic databases. This would ultimately help to pr...

Whole Genome Sequencing in the Detection of Rare Undiagnosed Genetic Diseases in Children in China

To assess the indications and diagnostic efficiency of whole genome sequencing (WGS) in pediatric patients with unexplained intellectual disability/developmental delay, multiple congenital...

Companies [1984 Associated Companies listed on BioPortfolio]

Recordati Rare Diseases Canada Inc.

Recordati Rare Diseases Canada Inc. is a biopharmaceutical company committed to providing often overlooked orphan therapies to underserved rare disease communities in Canada. Reco...

ArTara Therapeutics

ArTara is a rare diseases therapeutics company focused on optimizing therapeutics for patients suffering from rare diseases where there is a significant unmet need. Our initial fo...

Biotechnology Industry Organization (BIO) and National Organization for Rare Disorders (NORD)

The National Organization for Rare Disorders (NORD), established in 1983, is the leading, independent nonprofit organization dedicated to helping all patients and families affecte...

Lundbeck Inc.

Lundbeck Inc. was established in March 2009 following the acquisition of Ovation Pharmaceuticals, Inc. by Lundbeck and has proven success in developing and commercializing high-ne...

RECORDATI CORPORATION

Recordati, established in 1926, is a European pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), dedicated to the research, development...

More Information about "Recordati Rare Diseases Canada Inc." on BioPortfolio

We have published hundreds of Recordati Rare Diseases Canada Inc. news stories on BioPortfolio along with dozens of Recordati Rare Diseases Canada Inc. Clinical Trials and PubMed Articles about Recordati Rare Diseases Canada Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Recordati Rare Diseases Canada Inc. Companies in our database. You can also find out about relevant Recordati Rare Diseases Canada Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record